2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow ART5803: new trials by email Literature Review of ART5803 trials Research Report on ART5803
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy Participants ART5803, Intravenous immunoglobulin (IVIG) - Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody, Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder) | Phase 1 | Completed | Arialys Therapeutics | 7 | 2025-02-25 | 2026-04-27 |
| Phase 1 Study of ART5803 in Healthy Participants ART5803 - Autoimmune Encephalitis | Phase 1 | Completed | Arialys Therapeutics | 64 | 2024-09-19 | 2026-04-27 |
Autoimmune Diseases of the Nervous System (2) · Encephalitis (2)
Australia (2)